Table of Contents:
1 REPORT PROLOGUE
2 INTRODUCTION
2.1 SCOPE OF STUDY
2.2 RESEARCH OBJECTIVE
2.3 ASSUMPTIONS & LIMITATIONS
2.3.1 ASSUMPTIONS
2.3.2 LIMITATIONS
2.4 MARKET STRUCTURE
3 RESEARCH METHODOLOGY
3.1 RESEARCH PROCESS
3.2 PRIMARY RESEARCH
3.3 SECONDARY RESEARCH
4 MARKET FACTOR ANALYSIS
4.1 PORTER'S FIVE FORCE ANALYSIS
4.1.1 BARGAINING POWER OF BUYER
4.1.2 BARGAINING POWER OF SUPPLIER
4.1.3 THREAT FROM SUBSTITUTE
4.1.4 THREAT FROM A NEW ENTRANT
4.1.5 INTENSITY OF COMPETITIVE RIVALRY
4.2 VALUE CHAIN ANALYSIS
4.2.1 DEVICE MANUFACTURERS
4.2.2 SOFTWARE DEVELOPERS
4.2.3 HEALTHCARE PROVIDERS
4.2.4 PATIENTS
5 MARKET DYNAMICS
5.1 INTRODUCTION
5.2 DRIVERS
5.2.1 RISE IN RISK FACTORS IS PROPELLING THE MARKET GROWTH
5.2.2 RISE IN DISEASES AND GROWING GERIATRICS POPULATION
5.2.3 UNMET NEEDS
5.2.4 GROWING AWARENESS OF SLEEP DISORDERS
5.2.5 TECHNOLOGICAL ADVANCEMENTS
5.3 RESTRAINTS
5.3.1 HIGH COST AND SCANTY PRESENCE OF SLEEP LABS
5.3.2 LATE AWARENESS AND DISCOMFORT
5.3.3 LONG-TERM DENTAL CHANGES
5.3.4 LACK OF EFFECTIVENESS AND EFFICACY
5.4 OPPORTUNITIES
5.4.1 UNTAPPED MARKET
5.4.2 RESEARCH AND DEVELOPMENT
5.4.3 PERSONALIZED AND CUSTOMISED SOLUTIONS
5.4.4 CONNECTED SOLUTIONS AND CLOUD BASED SYSTEMS
5.5 CHALLENGES
5.5.1 POOR STANDARDIZATION
5.5.2 SUB-STANDARD PRODUCTS
6 GLOBAL DENTAL SLEEP MEDICINE MARKET, BY TREATMENT & DIAGNOSTICS
6.1 INTRODUCTION
6.2 TREATMENTS
6.3 DIAGNOSTICS
7 GLOBAL DENTAL SLEEP MEDICINE MARKET, BY END USERS
7.1 INTRODUCTION
7.2 HOSPITALS & SLEEP LABORATORIES
7.3 HOME
8 GLOBAL DENTAL SLEEP MEDICINE MARKET, BY REGION
8.1 INTRODUCTION
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 EUROPE
8.3.1 Germany
8.3.2 France
8.3.3 UK
8.3.4 Italy
8.3.5 SPAIN
8.3.6 REST OF EUROPE
8.4 ASIA PACIFIC
8.4.1 JAPAN
8.4.2 China
8.4.3 India
8.4.4 AUSTRALIA
8.4.5 REPUBLIC OF KOREA
8.4.6 REST OF ASIA PACIFIC
8.5 MIDDLE EAST AND AFRICA
8.5.1 MIDDLE EAST
8.5.2 AFRICA
9 COMPANY PROFILING
9.1 KONINKLIJKE PHILIPS N.V.
9.1.1 COMPANY OVERVIEW
9.1.2 FINANCIAL OVERVIEW
9.1.3 KEY DEVELOPMENTS
9.1.4 SWOT ANALYSIS
9.2 RESMED
9.2.1 COMPANY OVERVIEW
9.2.2 FINANCIAL OVERVIEW
9.2.3 KEY DEVELOPMENTS
9.2.4 SWOT ANALYSIS
9.3 FISHER & PAYKEL HEALTHCARE
9.3.1 COMPANY OVERVIEW
9.3.2 FINANCIAL OVERVIEW
9.3.3 KEY DEVELOPMENTS
9.3.4 SWOT ANALYSIS
9.4 DRIVE DEVILBISS HEALTHCARE
9.4.1 COMPANY OVERVIEW
9.4.2 FINANCIAL OVERVIEW
9.4.3 KEY DEVELOPMENTS
9.4.4 SWOT ANALYSIS
9.5 CURATIVE MEDICAL INC.
9.5.1 COMPANY OVERVIEW
9.5.2 FINANCIAL OVERVIEW
9.5.3 KEY DEVELOPMENT
9.5.4 SWOT ANALYSIS
9.6 APEX MEDICAL CORPORATION
9.6.1 COMPANY OVERVIEW
9.6.2 FINANCIAL OVERVIEW
9.6.3 KEY DEVELOPMENTS
9.7 BMC MEDICAL CO. LTD.
9.7.1 COMPANY OVERVIEW
9.7.2 FINANCIAL OVERVIEW
9.8 BECTON, DICKINSON AND COMPANY
9.8.1 COMPANY OVERVIEW
9.8.2 FINANCIAL OVERVIEW
9.8.3 KEY DEVELOPMENTS